Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis von Thuita, John K, Wang, Michael Z, Kagira, John M, Denton, Cathrine L, Paine, Mary F, Mdachi, Raymond E, Murilla, Grace A, Ching, Shelley, Boykin, David W, Tidwell, Richard R, Hall, James E, Brun, Reto

Volltext

Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice von Denton, Cathrine L, Gustafson, Daniel L

Volltext

Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation-Positive Solid Tumors von Denton, Cathrine L., Minthorn, Elisabeth, Carson, Stanley W., Young, Graeme C., Richards-Peterson, Lauren E., Botbyl, Jeffrey, Han, Chao, Morrison, Royce A., Blackman, Samuel C., Ouellet, Daniele

Volltext

Abstract 3773: Absolute bioavailability of BRAF inhibitor GSK2118436: Use of a microtracer study in patients with cancer von Denton, Cathrine L., Carson, Stanley W., Young, Graeme C., Richards-Peterson, Lauren E., Botbyl, Jeffrey, Morrison, Royce A., Blackman, Samuel C., Ouellet, Daniele

Volltext

Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates von Haynes, Barton F., Ma, Benjiang, Montefiori, David C., Wrin, Terri, Petropoulos, Christos J., Sutherland, Laura L., Scearce, Richard M., Denton, Cathrine, Xia, Shi-Mao, Korber, Bette T., Liao, Hua-Xin

Volltext